OXTELLAR XR

LIVE

Serial Number

85732114

Owner

SUPERNUS PHARMACEUTICALS, INC.

Attorney

Mark D. Simpson

First Use Date

Feb 28, 2013

Filing Date

Sep 18, 2012

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OXTELLAR XR Trademark

Serial Number: 85732114 • Registration: 4441262

OXTELLAR XR is a trademark filed by SUPERNUS PHARMACEUTICALS, INC. on September 18, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

SUPERNUS PHARMACEUTICALS, INC. (49 trademarks)

1550 EAST GUDE DRIVE
ROCKVILLE, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Mark D. Simpson

687 trademarks filed View all →

Correspondence Address

Mark D. Simpson Saul Ewing LLP

1500 Market Street

Centre Square West

38th Floor

Philadelphia

Trademark Details

Filing Date

September 18, 2012

Registration Date

November 26, 2013

First Use Anywhere

February 28, 2013

First Use in Commerce

February 28, 2013

Published for Opposition

March 12, 2013

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Apr 8, 2024 NA89

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

Apr 8, 2024 RNL1

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

Apr 8, 2024 89AG

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 8, 2024 APRE

TEAS SECTION 8 & 9 RECEIVED

Nov 27, 2023 E89R

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Nov 26, 2022 REM2

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Jan 18, 2020 NA85

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Jan 18, 2020 C15A

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Jan 18, 2020 APRE

TEAS SECTION 8 & 15 RECEIVED

Nov 26, 2019 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Nov 26, 2018 REM1

REGISTERED-PRINCIPAL REGISTER

Nov 26, 2013 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Oct 25, 2013 SUNA

LAW OFFICE REGISTRATION REVIEW COMPLETED

Oct 24, 2013 REGV

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Oct 22, 2013 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Oct 19, 2013 SUPC

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 11, 2013 AITU

USE AMENDMENT FILED

Sep 13, 2013 IUAF

TEAS STATEMENT OF USE RECEIVED

Sep 13, 2013 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 7, 2013 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 12, 2013 NPUB

PUBLISHED FOR OPPOSITION

Mar 12, 2013 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 20, 2013 NONP

LAW OFFICE PUBLICATION REVIEW COMPLETED

Feb 1, 2013 PREV

ASSIGNED TO LIE

Jan 31, 2013 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 18, 2013 CNSA

EXAMINER'S AMENDMENT ENTERED

Jan 18, 2013 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 18, 2013 GNEN

EXAMINERS AMENDMENT E-MAILED

Jan 18, 2013 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jan 18, 2013 CNEA

ASSIGNED TO EXAMINER

Jan 14, 2013 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 21, 2012 NWOS

NEW APPLICATION ENTERED

Sep 21, 2012 NWAP

Related Trademarks

More from this Owner

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES

ONCE-A-DAY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG

More in Same Class

GAMMAGOLD

CHOLESTRA

CHARCOLIVE

RAPID VIEW

YETARBA XR

BVB 09